 - Pregnant positive pregnancy test within 14 days of study enrollment or breast-feeding. Gemcitabine and carboplatin are pregnancy category D - clear evidence of risk in pregnancy; bevacizumab is pregnancy category C - risk in pregnancy cannot be ruled out. Pregnancy testing is not required for post-menopausal defined as absence of menses for the preceding 24 consecutive months or surgically sterilized women. 